# Cytochrome P450 2C19 Variant is Related to Pharmacokinetics of Glipizide Extended Release Tablet in Chinese Subjects

> **NCT01082796** · NA · COMPLETED · sponsor: **Chinese Academy of Sciences** · enrollment: 14 (actual)

## Conditions studied

- Genotype
- Pharmacokinetic

## Interventions

- **DRUG:** Glipizide

## Key facts

- **NCT ID:** NCT01082796
- **Lead sponsor:** Chinese Academy of Sciences
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** —
- **Final completion:** 2010-01
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2010-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01082796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01082796, "Cytochrome P450 2C19 Variant is Related to Pharmacokinetics of Glipizide Extended Release Tablet in Chinese Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01082796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*